Andrew Nguyen

Andrew Nguyen is a Research Associate II at Addition Therapeutics, where Andrew is involved in transforming genetic medicine with RNA-only therapeutics. Prior to this role, Andrew held similar positions at Sangamo Therapeutics, Inc., 10x Genomics, and System Biosciences, where Andrew worked on projects related to DNA binding affinities, assay development, and production of molecular biology research tools. Andrew holds a Bachelor's degree in Molecular and Cell Biology with a focus on Immunology and Pathogenesis from the University of California, Berkeley.